Superworth

Mettler-Toledo International price to free cash flow MTD

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Nov 3, 2026
39.6×
10-year median
38.0×
Against its 10-year history
61st
percentile: 0 is its lowest day, 100 its highest
10-year range
24.3× to 53.0×
Peer median
29.0×

Mettler-Toledo International's price to free cash flow is 39.6× as of Nov 3, 2026.

That is above its ten-year median of 38.0×, close to the middle of its last ten years.

Over that time it ranged from 24.3× in Apr 2025 to 53.0× in Feb 2023.

The median for 10 diagnostics and research stocks of a similar size is 29.0×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far38.9×26.3×38.9×
202532.6×24.3×34.8×
202429.7×28.2×36.0×
202330.2×25.0×53.0×
202248.1×33.7×49.5×
202147.9×39.3×49.7×
202045.8×30.0×47.5×
201940.0×33.6×47.2×
201835.5×34.7×51.2×
201745.9×31.1×49.3×
201631.4×24.1×32.8×
201526.8×22.7×28.9×
201429.0×23.2×29.0×
201327.8×25.9×31.1×
201226.2×24.2×41.2×
201133.1×28.3×37.4×

Against its peers

Companies in Medical - Diagnostics & Research nearest Mettler-Toledo International's size, closest first, today.

CompanyPrice to free cash flow
MTDMettler-Toledo International39.6×
ILMNIllumina38.4×
LHLabcorp25.0×
DGXQuest Diagnostics20.0×
IQVIQVIA19.4×
WATWaters117×
AAgilent Technologies39.1×
IDXXIDEXX Laboratories41.5×
MEDPMedpace25.6×
RVTYRevvity30.3×
BIOBio-Rad Laboratories27.7×
Peer median29.0×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Mettler-Toledo International

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.